Xxi Wealth, Llc
Source: SEC Form 13F · as of Mar 2026Xxi Wealth, Llc holds 19 biotech & pharma companies tracked by BioSniper, totaling $20.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$20.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 13,676 | $3.3M |
| LLYELI LILLY & Co | 3,040 | $2.8M |
| AZNASTRAZENECA PLC | 11,247 | $2.2M |
| ABTABBOTT LABORATORIES | 17,435 | $1.8M |
| ABBVAbbVie Inc. | 7,164 | $1.6M |
| MRKMerck & Co., Inc. | 10,277 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 7,791 | $1.1M |
| BMYBRISTOL MYERS SQUIBB CO | 15,119 | $917K |
| PFEPFIZER INC | 30,819 | $865K |
| ELVElevance Health Inc. | 2,942 | $861K |
| CAHCardinal Health Inc. | 3,564 | $753K |
| BIIBBIOGEN INC. | 3,651 | $669K |
| AMGNAMGEN INC | 1,653 | $582K |
| PMPhilip Morris International Inc | 2,835 | $469K |
| GMOptec International, Inc. | 5,816 | $433K |
| NVSNovartis AG | 2,468 | $377K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,335 | $361K |
| IDXXIDEXX LABORATORIES INC /DE | 471 | $265K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 466 | $208K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.